Madeglucyl is the first antidiabetic exclusively vegetable seeds removed Eugenia jambolana Lamarck whose beneficial properties are known in diabetes from the Indian Vedic era.
Madeglucyl lowers blood glucose in diabetic subjects but without exposing the patient to the risk of hypoglycemia when used alone; it is a true diabetes.
It appears that this effect results from a peripheral increase in glucose utilization.
Madeglucyl not stimulate insulin secretion, but the presence of small quantities of insulin is necessary for their action.
Diabetic patient, it reduces cholesterol. It improves impaired renal function (reduction of albuminuria).
Madeglucyl has no toxicity.
Associated with the low-carb diet and hypocalcic
Diabetes type II (obese diabetes, fifty diabetes, diabetes methapléthorique) having no acetonuria.
In addition to insulin therapy in:
insulin-dependent (or it can gradually reduce the dose of insulin)
In addition to declines sulphonylureas when they do not provide a sufficient decrease in blood sugar.
Madeglucyl should not be used as a treatment in isolated:
diabetes type I (insulin dependent)
aceto-ketotic diabetes, diabetic pre-coma
it should not be used during pregnancy.
precautions for use
Using Madeglucyl does not exempt the low-carb diet and calorie needs.
Biological controls should be regularly practiced.
instructions and dosage
The dosage is from:
4-6 sachets or capsules of 500 mg per day before meals 3